The observable consequence is the most potent weight- and glucose-lowering profile of any molecule approved before retatrutide: SURMOUNT-1 reported roughly 22.5% weight reduction at the 15 mg dose over 72 weeks 13, and SURMOUNT-5 showed tirzepatide superior to semaglutide 2.4 mg head-to-head at 72 weeks (20.2% vs 13.7%) 18
Fact: Most mood changes are temporary adjustments to metabolic shifts, physical side effects, or the psychological impact of a significant lifestyle change
Once they have been on the 2.4mg dose for 4 weeks, they can titrate up to the new dose of 7.2mg The official Wegovy dosing schedule recommended by clinicians is as follows: If the user is taking the 2.4 mg dose and is happy with their current progress, or isn't noticing a plateau in their weight loss, they can choose to remain on this dose rather than increase to 7.2 mg
10 mg vial: Reconstituting 10 mg with 2 mL (200 units) gives 0.05 mg per unit
In terms of helping with weight loss, semaglutide affects the brain signals that control appetite and food intake, making a person feel less hungry and more satisfied with smaller portions, contributing to weight loss
